4.7 Article

Incorporating natural anti-inflammatory compounds into yeast glucan particles increases their bioactivity in vitro

Journal

INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES
Volume 169, Issue -, Pages 443-451

Publisher

ELSEVIER
DOI: 10.1016/j.ijbiomac.2020.12.107

Keywords

beta-glucan microparticles; Drug carrier; Inflammation; Monocytes; Natural compounds; Pharmaceutical composite

Funding

  1. Ministry of Health of the Czech Republic [16-27522A]
  2. Ministry of Education, Youth and Sports of the Czech Republic under the project FIT [CZ.02.1.01/0.0/0.0/15_003/0000495]
  3. Czech Ministry of Agriculture [RO0518]

Ask authors/readers for more resources

The study found that combining several natural compounds with yeast GPs can enhance their anti-inflammatory and antioxidant potential, showing stronger activity in vitro. Composites prepared by spray drying demonstrated better performance than those prepared by slurry evaporation.
Yeast glucan particles (GPs) are promising agents for the delivery of biologically active compounds as drugs. GPs possess their own biological activities and can act synergistically with their cargo. This study aimed to determine how incorporating artemisinin, ellagic acid, (-)-epigallocatechin gallate, morusin, or trans-resveratrol into GPs affects their anti-inflammatory and antioxidant potential in vitro. Two different methods - slurry evaporation and spray drying - were used to prepare composites (GPs+ bioactive compound) and the anti-inflammatory and antioxidative properties of the resultant products were compared. Several of the natural compounds showed the beneficial effects of being combined with GPs. The materials prepared by spray drying showed greater activity than those made using a rotary evaporator. Natural compounds incorporated into yeast GPs showed greater anti-inflammatory potential in vitro than simple suspensions of these compounds as demonstrated by their inhibition of the activity of transcription factors NF-kappa B/AP-1 and the secretion of the pro-inflammatory cytokine TNF alpha. (C) 2020 Elsevier B.V. All rights reserved.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available